All News

The inventors of an imaging system to improve diagnosis of coronary heart disease are looking at licensing the technology – or getting venture capital to create a spin-out.

A researcher at the Academic Medical Centre in Amsterdam has developed instruments that could assist surgeons to perform keyhole surgery. The centre is now looking for investors and partnership or licensing agreements for the technology.

Cognitive science is moving rapidly from theory to research to practical applications.

The conclusion that there was nothing wrong with the specifics of the TeGenero trial in which six healthy volunteers ended up in intensive care has repercussions for the wider biotech industry.

Things have changed in intellectual property, the biotech industry's big annual get-together in the US has been hearing from India, Malaysia and others.

The European Union's plan to transform Europe's drug discovery industry borrows some of its style from the US - but not everything.

The European biotechnology sector is back on track, according to Ernst & Young's 20th annual survey of biotechnology.

Europe needs more "angel" investors to finance its start-ups. A Prague conference highlights why it isn't getting them.

A University of Plymouth graduate has invented a machine that combines washing, drying and ironing functions with the touch of a button, and he is now looking for investment of up to £5 million to refine the product for the general household use.

Innovation has its phases. So does procurement. The challenge is to synchronise them.

What happens to the company labs when there’s a merger? That’s the question many in the telecoms industry are now asking, following news of merger plans by US-based Lucent and France's Alcatel.

While the telecommunications industry retrenches, the dominant French operator expands its research budget and seeks new lab partners. Why?

Endoart SA, a Swiss company which develops medical devices for the obese, said it has raised CHF13.5 million ($10.5 million) in a series C financing from venture capital funds for product development and clinical trials.

The European University Association presents a vision for universities, with a few pointers to issues in knowledge transfer.

More and more universities are desperate to show that they have a positive effect on the local economy. Here's one from the US.